Note: Not guaranteed to come with supplemental materials (access cards, study guides, lab manuals, CDs, etc.)
Extend Your Rental at Any Time
Need to keep your rental past your due date? At any time before your due date you can extend or purchase your rental through your account.
Sorry, this item is currently unavailable.
Cancer incidences increase in people living with HIV/AIDS. Over 2 Million people currently live with HIV/AIDS in the US. This number will increase as HAART prolongs the average lifespan and as (at least in some states) the number of new HIV infections increase again. As this population ages their incidence rates for cancer will increase, as well. Recently, new rational targets for cancer therapy have emerged. But their application to the care of HIV+ patients is slow, because of concerns about the weakened immune status of the patients, because of possible drug interactions with HAART and because some of the AIDS defining cancer are rare.
Table of Contents
The Epidemiology of Cancer in People with HIV
Epidemiology and Clinical Characteristics of Non-AIDS-Defining Malignancies
HIV-Related Cancer Management in Resource-Limited Settings: A Case Study of Malawi
Immunology of HIV-Associated Kaposi Sarcoma
Targeting Signal Transduction Pathways for the Treatment of Kaposi Sarcoma
Role of NF-kB Inhibitors in HIV-Related Malignancies
The Molecular Basis of Lytic Induction Therapy in Relation to Gamma herpesvirus (KSHV, EBV)-Associated, AIDS-Related Tumors
Viral Interleukin-6: Molecular Biology and Pathogenesis
Targeting the PI3K/Akt/mTOR Pathway in AIDS-Associated Malignancies
Restoration of p53 Function by MDM2 Inhibition: Potential Strategy to Treat KSHV-Associated Malignancies
Interferon in Kaposi's Sarcoma Biology and Therapy
Metronomic Therapy for HIV-Associated Malignancies
Targeting EGFR in HPV-Associated Cancer
Cidofovir Against Human Papillomavirus-Associated Diseases
Table of Contents provided by Ingram. All Rights Reserved.